Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide-Reference-Cited by-同舟云学术

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Published:2012-05-03 Issue:11 Volume:26 Page:2326-2335
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Lopez-Girona A,Mendy D,Ito T,Miller K,Gandhi A K,Kang J,Karasawa S,Carmel G,Jackson P,Abbasian M,Mahmoudi A,Cathers B,Rychak E,Gaidarova S,Chen R,Schafer P H,Handa H,Daniel T O,Evans J F,Chopra R

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012119.pdf

Reference33 articles.

1. Bartlett JB, Dredge K, Dalgleish AG . The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat Rev Cancer 2004; 4: 314–322.

2. Teo SK . Properties of thalidomide and its analogues: implications for anticancer therapy. AAPS J 2005; 7: E14–E19.

3. Davies FE, Raje N, Hideshima T, Lentzsch S, Young G, Tai YT et al. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood 2001; 98: 210–216.

4. Dredge K, Marriott JB, Macdonald CD, Man HW, Chen R, Muller GW et al. Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer 2002; 87: 1166–1172.

5. Zeldis JB, Knight R, Hussein M, Chopra R, Muller G . A review of the history, properties, and use of the immunomodulatory compound lenalidomide. Ann N Y Acad Sci 2011; 1222: 76–82.

Cited by 661 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulation and anticancer evaluation of quinazoline-based thalidomide analogs: Design, synthesis, docking, and dynamic simulation;Journal of Molecular Structure;2024-12

2. FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives;European Journal of Medicinal Chemistry;2024-11

3. Unlocking the Immunomodulatory Potential of Rosmarinic Acid Isolated from Punica granatum L. using Bioactivity-Guided Approach: In Silico, In Vitro, and In Vivo Approaches;Current Medicinal Chemistry;2024-11

4. Lys-63-specific deubiquitinase BRCC36 enhances the sensitivity of multiple myeloma cells to lenalidomide by inhibiting lysosomal degradation of cereblon;Cellular and Molecular Life Sciences;2024-08-13

5. Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy;Trends in Molecular Medicine;2024-08